Emil Kakkis Net Worth & Insider Trades

Emil Kakkis - President & CEO, Ultragenyx Pharmaceutical Inc

As of January 3, 2023

What is Emil Kakkis's Net Worth?

The current estimated net worth of Ultragenyx Pharmaceutical Inc's President & CEO, Emil Kakkis, is estimated to be about $69.61M . Emil Kakkis owns about 2,824,385 units of Ultragenyx Pharmaceutical Inc common stock. In the last 6 years at Ultragenyx Pharmaceutical Inc, Emil Kakkis has sold an estimated value of $25.97M worth.

What is Emil Kakkis's Past Insider Trading?

Emil Kakkis's largest purchase order was 7,500 units , worth over $393.92K on August 29, 2017. Emil Kakkis's largest sale order was 46,342 units , worth over $6.58M on March 3, 2021. In total, Emil Kakkis has made about 31 transactions over 6 years of their time at Ultragenyx Pharmaceutical Inc. Emil Kakkis usually trades in March and May, with the busiest year in 2020. The most recent transaction was a sale order of 19,582 units , worth over $892.35K on January 3, 2023.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Emil Kakkis's' Mailing Address?

  • Mailing address is C/o Ultragenyx Pharmaceutical Inc. 60 Leveroni Court Novato CA 94949 CA

What are Ultragenyx Pharmaceutical Inc's Past Insider Trades?

Ultragenyx Pharmaceutical Inc's most recent insider trade came on January 3, 2023 by Emil Kakkis who sold 19,582 units worth $892.35K . In the last 8 years, insiders at Ultragenyx Pharmaceutical Inc have sold an estimated value of $119.09M and bought an estimated value of $17.87M worth of shares. Insider trading is most common in June, with the busiest year in 2020. The most active traders at the company are Shalini Sharp, EVP,  Alan Theodore Huizenga, SVP,  and Emil Kakkis, President & CEO .

Ultragenyx Pharmaceutical Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1